Kyverna Therapeutics Cash Flow Statement (2023-2026) | KYTX

Cash Flow Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -11.66M-13.64M-16.00M-19.01M-28.42M-41.37M-43.29M-40.42M-45.55M-44.21M-52.85M-40.87M-74.16M
Share-based Compensation (Quarter) 468.000.45M0.52M0.78M2.28M1.28M3.41M1.38M0.20M2.52M2.70M2.70M39.50M
Asset Writedowns and Impairment (Quarter) 0.65M
Cash from Operations (Quarter) -11.46M-11.26M-11.13M-18.56M-25.52M-24.18M-27.49M-37.06M-44.90M-31.96M-43.32M-33.52M-41.60M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.08M-0.01M0.44M0.60M0.28M2.25M2.89M2.24M2.11M1.84M1.57M1.37M0.73M
Amortization of Deferred Charges (Quarter) 0.11M
Depreciation & Amortization (CF) (Quarter) 0.39M0.41M0.44M0.46M0.48M0.53M0.56M0.56M0.50M0.52M0.41M0.37M0.35M
Change in Working Capital
Change in Account Payables (Quarter) 0.10M0.49M0.51M2.98M3.07M-2.10M5.07M-5.30M3.78M1.41M-6.80M-0.89M6.28M
Change in Accured Expenses (Quarter) -0.78M0.50M0.72M0.96M-1.45M1.36M1.72M0.44M-1.80M1.89M1.99M3.03M-6.88M
Other Working Capital Changes (Quarter) -0.34M-0.43M-0.44M-0.46M-0.52M-0.61M-0.62M-0.65M-0.96M-0.76M1.72M-3.34M-0.50M
Investing Activities
Capital Expenditures (Quarter) 0.03M-0.16M0.42M1.56M0.09M-0.09M0.99M0.96M0.52M-0.01M-0.50M1.12M0.01M
Change in Acquisitions & Divestments (Quarter) 13.68M33.00M23.00M13.00M138.30M157.00M86.70M124.10M95.70M99.20M65.70M
Cash from Investing Activities (Quarter) 13.65M-0.00M-54.12M31.68M-122.88M-67.92M0.68M29.22M5.58M29.17M22.56M-17.29M-50.20M
Financing Activities
Other financing activities (Quarter) 0.02M0.04M0.31M0.28M341.17M-341.03M0.09M340.94M0.00M-0.00M1.99M0.24M
Change in Capital Stock
Shares Issued (Quarter) 4.31M4.23M4.17M7.11M7.60M1.81M9.94M9.44M9.33M10.66M
Net Equity Issued and Repurchased (Quarter) 34.84M
Misc.
Cash from Financing Activities (Quarter) -0.14M24.91M34.79M-1.43M338.05M-0.57M-0.15M-0.21M-0.41M-0.65M1.49M140.74M-0.10M
Change in Cash (Quarter) 2.05M13.65M-30.46M11.68M189.65M-92.67M-26.96M-8.05M-39.75M-3.43M-19.28M89.93M-91.90M
Free Cash Flow (Quarter) -11.49M-11.09M-11.55M-20.12M-25.61M-24.09M-28.48M-38.02M-45.41M-31.95M-42.82M-34.64M-41.60M
Net Cash Flow (Quarter) 2.05M13.65M-30.46M11.68M189.65M-92.67M-26.96M-8.05M-39.74M-3.45M-19.28M89.94M-91.90M